These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 6541096)
1. Murine leukemia L1210 cell lines with different patterns of resistance to platinum coordination complexes. Eastman A; Illenye S Cancer Treat Rep; 1984 Sep; 68(9):1189-90. PubMed ID: 6541096 [TBL] [Abstract][Full Text] [Related]
2. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines. Yoshida M; Khokhar AR; Siddik ZH Cancer Res; 1994 Jul; 54(13):3468-73. PubMed ID: 8012968 [TBL] [Abstract][Full Text] [Related]
3. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes. Siddik ZH; al-Baker S; Thai G; Khokhar AR Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929 [TBL] [Abstract][Full Text] [Related]
4. Circumvention of platinum resistance: structure-activity relationship for homologous series of ammine/amine platinum(II) complexes in L1210 cell lines. Yoshida M; Khokhar AR; Siddik ZH Anticancer Drug Des; 1994 Oct; 9(5):425-34. PubMed ID: 7945726 [TBL] [Abstract][Full Text] [Related]
5. Drug resistance induction and cross-resistance studies with Pt-complexes. Hrubisko M; Balázová E; Ujházy V Neoplasma; 1984; 31(6):649-53. PubMed ID: 6542968 [TBL] [Abstract][Full Text] [Related]
6. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours. Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631 [TBL] [Abstract][Full Text] [Related]
7. The role of platinum uptake and glutathione levels in L1210 cells sensitive and resistant to cisplatin, tetraplatin or carboplatin. Nicolson MC; Orr RM; O'Neill CF; Harrap KR Neoplasma; 1992; 39(3):189-95. PubMed ID: 1528325 [TBL] [Abstract][Full Text] [Related]
8. Role of carrier ligand in platinum resistance in L1210 cells. Gibbons GR; Page JD; Mauldin SK; Husain I; Chaney SG Cancer Res; 1990 Oct; 50(20):6497-501. PubMed ID: 2208108 [TBL] [Abstract][Full Text] [Related]
9. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug. Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318 [TBL] [Abstract][Full Text] [Related]
10. The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts. Goddard P; Valenti M; Kelland LR Anticancer Res; 1994; 14(3A):1065-70. PubMed ID: 8074451 [TBL] [Abstract][Full Text] [Related]
11. Antitumor activity and cross-resistance studies with Pt-ascorbato complexes. Hrubisko M; Balázová E; Kiss F; Kovácová J; Ujházy V Neoplasma; 1989; 36(6):651-7. PubMed ID: 2615869 [TBL] [Abstract][Full Text] [Related]
12. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV). Yoshida M; Khokhar AR; Siddik ZH Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266 [TBL] [Abstract][Full Text] [Related]
13. [Testing antineoplastic activity of new platinum(II) and palladium(II) complex compounds]. Malinowska K; Modranka R; Kubiak K; Mrowicka M; Klimczak A; Kedziora J; Rutkowski M Pol Merkur Lekarski; 2009 Jan; 26(151):57-61. PubMed ID: 19391509 [TBL] [Abstract][Full Text] [Related]
14. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo. Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide. Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821 [TBL] [Abstract][Full Text] [Related]
16. Re: Effects of bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line. Wyrick SD; Chaney SG Cancer Res; 1987 Sep; 47(18):4992. PubMed ID: 3621186 [No Abstract] [Full Text] [Related]
17. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex. Noji M; Kizu R; Takeda Y; Akiyama N; Yoshizaki I; Eriguchi M; Kidani Y Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175 [TBL] [Abstract][Full Text] [Related]
18. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands. Kido Y; Khokhar AR; al-Baker S; Siddik ZH Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629 [TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of four polymer bound trans-1,2-diaminocyclohexaneplatinum(II)-4-carboxyphtalate complexes tested in different model systems. Balázová E; Hrubisko M; Drobník J; Ujházy V Neoplasma; 1986; 33(6):665-70. PubMed ID: 3808121 [TBL] [Abstract][Full Text] [Related]
20. Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles. Perez-Soler R; Khokhar AR; Lopez-Berestein G Cancer Res; 1987 Dec; 47(24 Pt 1):6462-6. PubMed ID: 3315188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]